These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37140765)

  • 21. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
    J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current glycaemic control has no impact on the advancement of diabetic neuropathy.
    Dziemidok P; Szcześniak G; Kostrzewa-Zabłocka E; Paprzycki P; Korzon-Burakowska A
    Ann Agric Environ Med; 2012; 19(4):742-5. PubMed ID: 23311800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical usefulness of the two-site Semmes-Weinstein monofilament test for detecting diabetic peripheral neuropathy.
    Lee S; Kim H; Choi S; Park Y; Kim Y; Cho B
    J Korean Med Sci; 2003 Feb; 18(1):103-7. PubMed ID: 12589096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilizing the Ipswich Touch Test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience.
    Madanat A; Sheshah E; Badawy el-B; Abbas A; Al-Bakheet A
    Prim Care Diabetes; 2015 Aug; 9(4):304-6. PubMed ID: 25466160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.
    Martin CL; Waberski BH; Pop-Busui R; Cleary PA; Catton S; Albers JW; Feldman EL; Herman WH;
    Diabetes Care; 2010 Dec; 33(12):2635-41. PubMed ID: 20833868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy.
    Mythili A; Kumar KD; Subrahmanyam KA; Venkateswarlu K; Butchi RG
    Int J Diabetes Dev Ctries; 2010 Jan; 30(1):43-8. PubMed ID: 20431806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of vibration perception threshold values in children and adolescents with type 1 diabetes mellitus and associated factors.
    Louraki M; Tsentidis C; Kallinikou D; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Papathanasiou A; Karavanaki K
    Prim Care Diabetes; 2014 Jul; 8(2):147-57. PubMed ID: 24315733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of sensory testing on different toe surfaces: implications for neuropathy screening.
    Dimitrakoudis D; Bril V
    Neurology; 2002 Aug; 59(4):611-3. PubMed ID: 12196660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.
    Goel A; Shivaprasad C; Kolly A; Sarathi H A V; Atluri S
    PLoS One; 2017; 12(9):e0183973. PubMed ID: 28880907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting.
    Bowling FL; Abbott CA; Harris WE; Atanasov S; Malik RA; Boulton AJ
    Diabet Med; 2012 Dec; 29(12):1550-2. PubMed ID: 22672290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple screening tests for peripheral neuropathy in the diabetes clinic.
    Perkins BA; Olaleye D; Zinman B; Bril V
    Diabetes Care; 2001 Feb; 24(2):250-6. PubMed ID: 11213874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements.
    McGill M; Molyneaux L; Spencer R; Heng LF; Yue DK
    Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
    Olaleye D; Perkins BA; Bril V
    Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood diabetic neuropathy: functional impairment and non-invasive screening assessment.
    Blankenburg M; Kraemer N; Hirschfeld G; Krumova EK; Maier C; Hechler T; Aksu F; Magerl W; Reinehr T; Wiesel T; Zernikow B
    Diabet Med; 2012 Nov; 29(11):1425-32. PubMed ID: 22507184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Measurement of vibratory threshold in the diagnosis of diabetic neuropathy].
    Ribera RL; Valls J; González-Clemente JM; Vidal J; Manzanares JM; Esmatjes E
    Rev Clin Esp; 1994 Oct; 194(10):901-5. PubMed ID: 7800871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Semmes Weinstein 10 gm monofilament in diabetic peripheral neuropathy taking nerve conduction and autonomic function study as reference tests.
    Dube S; Hulke SM; Wakode SL; Khadanga S; Thakare AE; Bharshankar RN; Pakhare A
    J Family Med Prim Care; 2022 Oct; 11(10):6204-6208. PubMed ID: 36618173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level.
    Azzopardi K; Gatt A; Chockalingam N; Formosa C
    Prim Care Diabetes; 2018 Apr; 12(2):111-115. PubMed ID: 29029862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the current evidence on the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus.
    Hu A; Koh B; Teo MR
    Diabetol Int; 2021 Apr; 12(2):145-150. PubMed ID: 33786269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated use of vibration perception thresholds and semmes-weinstein monofilament in diagnosing diabetic polyneuropathy: "the North Catalonia diabetes study".
    Jurado J; Ybarra J; Pou JM
    Nurs Clin North Am; 2007 Mar; 42(1):59-66. PubMed ID: 17270590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.